Funds · compare two funds
Are these two funds really different?
Pick two funds to see how much of their Indian equity is the same: the companies both hold, and what each holds that the other does not.
Data periodFund holdingsEach fund’s latest monthly disclosureNSE prices23 Oct 2026Data status →
ADITYA BIRLA SUN LIFE PHARMA & HEALTHCARE FUND vs Mirae Asset Healthcare Fund
Overlap adds up, for every company both funds hold, the smaller of its two shares of each fund’s disclosed Indian equity: identical portfolios overlap 100%, funds with nothing in common 0%. A figure describes how alike the portfolios are; it is not a judgement of either fund. Method →
See both funds combined in the Portfolio X-ray →
Top shared holdings
18 companies both funds hold · largest common part first
Only in A
21 companies · largest first
- Ajanta Pharma Limited4.44%
- Abbott India Limited3.32%
- Emcure Pharmaceuticals Limited3.27%
- CORONA Remedies Limited2.32%
- Procter & Gamble Health Limited1.86%
- Thyrocare Technologies Limited1.79%
- Jupiter Life Line Hospitals Limited1.58%
- Metropolis Healthcare Limited1.51%
- Shilpa Medicare Limited1.46%
- Piramal Pharma Limited1.25%
- Sanofi Consumer Healthcare India Limited1.14%
- Suraksha Diagnostic Limited1.13%
- Manipal Health Enterprises Limited1.09%
- Vijaya Diagnostic Centre Limited1.07%
- Pfizer Limited1.03%
And 6 more.
Only in B
11 companies · largest first
- Laurus Labs Limited5.51%
- Glenmark Pharmaceuticals Limited4.78%
- Krishna Institute of Medical Sciences Limited3.39%
- Aster DM Quality Care Limited3.33%
- Onesource Specialty Pharma Limited3.01%
- Eris Lifesciences Limited2.39%
- Molbio Diagnostics Limited1.77%
- Symbiotec Pharmalab Limited1.60%
- Neogen Chemicals Limited1.50%
- Deepak Nitrite Limited0.40%
- Narayana Hrudayalaya Ltd.0.00%
Sector mix side by side
Share of each fund’s disclosed equity
| Sector | A | B | Difference |
|---|---|---|---|
| Healthcare | 91.3% | 94.7% | -3.44 pp |
| Not classified | 8.7% | 3.4% | +5.34 pp |
| Chemicals | 0.0% | 1.9% | -1.90 pp |
Built from each fund’s latest monthly disclosure of Indian listed shares, valued at official NSE closing prices. Cash, debt, derivatives and overseas holdings are not part of the comparison. Not a recommendation. Method →